CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Akero Fiscal Q1 2023 Earnings Report - CapyFin

Akero

AKRO · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q3 2025 +0.20%Q2 2025 +0.08%Q1 2025 +4.30%Q4 2024 +2.87%Q3 2024 -5.25%Q2 2024 -2.97%Q1 2024 -0.87%Q4 2023 +2.13%Q3 2023 +5.30%Q2 2023 +6.16%Q1 2023 +0.15%Q4 2022 -4.10%Q3 2022 -6.81%Q2 2022 +18.38%Q1 2022 -11.39%Q4 2021 -1.94%Q3 2021 +4.56%Q2 2021 +0.97%Q1 2021 +2.58%Q4 2020 -1.06%Q3 2020 -3.02%Q2 2020 -0.92%Q1 2020 +2.83%Q4 2019 -20.89%Q3 2019 -3.77%Q2 2019 +1.27%Q1 2019 Q4 2018 Q3 2018 Q2 2018 Q1 2018 Q4 2017

May 15, 2023

•

Mar 31, 2023

Akero Q1 2023 Earnings Report

Akero Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2023.

Key Takeaways

Akero Therapeutics, Inc. announced its financial results for the quarter ended March 31, 2023.

Previous year: -$0.74

Cash and Equivalents

Previous year: $165M

Previous year: $170M

Akero

Unlock previous datapoints

Akero

Unlock previous datapoints

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis